Form 8-K - Current report:
SEC Accession No. 0001193125-22-171470
Filing Date
2022-06-10
Accepted
2022-06-10 07:00:55
Documents
12
Period of Report
2022-06-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d313676d8k.htm   iXBRL 8-K 28133
  Complete submission text file 0001193125-22-171470.txt   157185

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vigl-20220609.xsd EX-101.SCH 2867
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vigl-20220609_lab.xml EX-101.LAB 19502
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vigl-20220609_pre.xml EX-101.PRE 12164
6 EXTRACTED XBRL INSTANCE DOCUMENT d313676d8k_htm.xml XML 3590
Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41200 | Film No.: 221007613
SIC: 2836 Biological Products, (No Diagnostic Substances)